When confronted with suspicions that an employee has misused or abused FMLA leave, employers have options, said Alexis Knapp, shareholder at Littler Mendelson. But those options must be exercised in a ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The Tennessee Comptroller of the Treasury has denied Shelby County Government's 2026 fiscal year budget. In a letter, obtained by The Commercial Appeal, Comptroller Jason Mumpower wrote to Shelby ...
Adrian Delia has confirmed the letter questioning the eligbility of some 100 votes was sent to the PN's electoral commission "with [his] blessing" but said it was in no way an attack on the final ...
I’ve been a teacher since 1992. When I went to college, I was taught that children would learn to read naturally if we simply surrounded them with books. My training emphasized "whole language," ...
The next time the FDA turns down a drug application, the letter outlining the decision and the regulator’s reasoning will become public record. The agency said it will release future complete response ...
What’s old is new again? In Vermont, one man is refurbishing payphones for people to use for free. Very cool. Debt isn’t old or new, but how we treat it is. On today's episode of Advisory Angle at 2PM ...
Why ODOT objects the new Browns stadium is beyond me. (Cleveland Browns ‘confused’ by state’s air-traffic objections to stadium plans, given feds’ prior OK) The FAA has cleared the way and ODOT is ...
Cardi B has released “Imaginary Playerz,” the latest single for her upcoming sophomore album, Am I The Drama?, out September 19. In the new track, Cardi B raps about fame and fashion over a sample of ...
A mortgage commitment letter is a crucial document in the homebuying process, indicating a lender's intent to provide a loan. It reassures sellers of a buyer's financial capability and outlines the ...
Findings from an FDA general site inspection were enough to delay the approval of odronextamab, as well as other pending applications. The Food and Drug Administration (FDA) has issued another ...